These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 9272198)

  • 21. A double-blind comparison of moclobemide and thioridazine versus moclobemide and placebo in the treatment of refractory, severe depression.
    Stabl M; Kasas A; Blajev B; Bajetta G; Zöchling R; Holsboer-Trachsler E; Realini R; Schäublin-Loidl M
    J Clin Psychopharmacol; 1995 Aug; 15(4 Suppl 2):41S-45S. PubMed ID: 7593730
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Moclobemide versus tranylcypromine in the treatment of depression.
    Rossel L; Moll E
    Acta Psychiatr Scand Suppl; 1990; 360():61-2. PubMed ID: 2248075
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A placebo-controlled study of the antidepressant activity of moclobemide, a new MAO-A inhibitor.
    Casacchia M; Carolei A; Barba C; Frontoni M; Rossi A; Meco G; Zylberman MR
    Pharmacopsychiatry; 1984 Jul; 17(4):122-5. PubMed ID: 6382361
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Effectiveness of moclobemide in therapy-resistant depression].
    Andriushchenko AV; Kolesnikov DB
    Zh Nevrol Psikhiatr Im S S Korsakova; 1998; 98(10):34-7. PubMed ID: 9819886
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Efficacy and safety of moclobemide compared with maprotiline in treatment of major depressive disorder. A double-blind multicenter study with parallel groups.
    Steinmeyer EM; Vorbach EU; Arnoldt KH
    Pharmacopsychiatry; 1993 Nov; 26(6):246-53. PubMed ID: 8127929
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A comparison of the efficacy and tolerability of moclobemide given as a single daily dose or in three divided doses per day for the treatment of patients with a major depressive episode (DSM-III-R).
    Newburn G; Edwards R; Thomas H; Collier J; Fox K; Collins C; Cramer D; Reeves J; Caracatsanis A
    J Clin Psychopharmacol; 1995 Aug; 15(4 Suppl 2):10S-15S. PubMed ID: 7593724
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Moclobemide compared with second-generation antidepressants in elderly people.
    De Vanna M; Kummer J; Agnoli A; Gentili P; Lorizio A; Anand R
    Acta Psychiatr Scand Suppl; 1990; 360():64-6. PubMed ID: 2248077
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Efficacy of a reversible monoamine oxidase-A inhibitor versus imipramine in subgroups of depressed patients.
    Bizière K; Berger M
    Acta Psychiatr Scand Suppl; 1990; 360():59-60. PubMed ID: 2248074
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Moclobemide versus imipramine in depressed out-patients: a double-blind multi-centre study.
    Rimón R; Jääskeläinen J; Kaartinen P; Kalli A; Kilponen E; Koskinen T; Nikkilä H; Pirttiperä V; Seppälä J
    Int Clin Psychopharmacol; 1993 Jan; 7(3-4):141-7. PubMed ID: 8468435
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Moclobemide: a paradigm of research in clinical psychopharmacology.
    Angst J; Amrein R; Stabl M
    Int Clin Psychopharmacol; 1996 Jun; 11 Suppl 3():3-7. PubMed ID: 8923103
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Switch in treatment from tricyclic antidepressants to moclobemide: a new generation monoamine oxidase inhibitor.
    Dingemanse J; Kneer J; Fotteler B; Groen H; Peeters PA; Jonkman JH
    J Clin Psychopharmacol; 1995 Feb; 15(1):41-8. PubMed ID: 7714227
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Antidepressant efficacy and quality of life in depression: a double-blind study with moclobemide and fluoxetine.
    Lonnqvist J; Sintonen H; Syvälahti E; Appelberg B; Koskinen T; Mannikko T; Mehtonen OP; Naarala M; Sihvo S; Auvinen J
    Acta Psychiatr Scand; 1994 Jun; 89(6):363-9. PubMed ID: 8085464
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Moclobemide and sertraline in the treatment of depressive disorders: a comparative study.
    Orsel Donbak S; Turkçapar MH; Ozturk Kiliç EZ; Demirergi N; Akdemir A; Sirin A; Ozbay MH
    Acta Psychiatr Belg; 1995; 95(3):139-51. PubMed ID: 8525856
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pirlindole in the treatment of depression and fibromyalgia syndrome.
    Branco JC; Tomé AM; Cruz MR; Filipe A
    Clin Drug Investig; 2011 Oct; 31(10):675-89. PubMed ID: 21877764
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Controlled comparison of RO 11-1163 (moclobemide) and placebo in the treatment of depression.
    Botte L; Evrard JL; Gilles C; Stenier P; Wolfrum C
    Acta Psychiatr Belg; 1992; 92(6):355-69. PubMed ID: 1345409
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Moclobemide versus amitriptyline in the treatment of depression: two small double-blind multicentre studies in Belgium.
    Beckers G; Vereecken A; de Bleeker E; Jaunes C; Sieben G; Faidherbe J; Wolfrum C; Berger M; Hellstern K; Ward J
    Acta Psychiatr Scand Suppl; 1990; 360():52-3. PubMed ID: 2248072
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparison of the efficacy and tolerability of moclobemide and maprotiline in depressed patients treated by general practitioners.
    Gachoud JP; Dick P; Köhler M
    Clin Neuropharmacol; 1994; 17 Suppl 1():S29-37. PubMed ID: 7954482
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Treatment of winter depression in Norway. II. A comparison of the selective monoamine oxidase A inhibitor moclobemide and placebo.
    Lingjaerde O; Reichborn-Kjennerud T; Haggag A; Gärtner I; Narud K; Berg EM
    Acta Psychiatr Scand; 1993 Nov; 88(5):372-80. PubMed ID: 8296582
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A double-blind placebo-controlled comparison of moclobemide and amitriptyline in the treatment of depression.
    Bakish D; Wiens A; Ellis J; Alda M; Lapierre Y
    Can J Psychiatry; 1992 Sep; 37 Suppl 1():12-7. PubMed ID: 1394026
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A double blind trial of moclobemide versus amitriptyline in the treatment of depressive disorders.
    Newburn GM; Fraser AR; Menkes DB; Mullen PE
    Aust N Z J Psychiatry; 1990 Dec; 24(4):475-9. PubMed ID: 2073222
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.